Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Teruki Teshima

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110735649. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 12

  1. The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization. Co-author DOI 10.1186/s12876-025-04108-2↗
  2. Improvement of image quality for pancreatic cancer using deep learning-generated virtual monochromatic images: Comparison with single-energy computed tomograph… Last author DOI 10.1016/j.ejmp.2021.03.035↗
  3. A Third-Generation Adaptive Statistical Iterative Reconstruction for Contrast-Enhanced 4-Dimensional Dual-Energy Computed Tomography for Pancreatic Cancer. Last author DOI 10.1097/rct.0000000000000942↗
  4. The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Ca… Co-author DOI 10.3390/cancers13184733↗
  5. Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer. Last author DOI 10.4251/wjgo.v12.i7.768↗
  6. Treatment planning based on water density image generated using dual-energy computed tomography for pancreatic cancer with contrast-enhancing agent: Phantom an… Last author DOI 10.1002/mp.13180↗
  7. Clinical implementation of contrast-enhanced four-dimensional dual-energy computed tomography for target delineation of pancreatic cancer. Last author DOI 10.1016/j.radonc.2018.01.012↗
  8. Risk factors for vertebral compression fractures in preoperative chemoradiotherapy with gemcitabine for pancreatic cancer. First author DOI 10.1016/j.radonc.2016.01.006↗
  9. Prospective small bowel mucosal assessment immediately after chemoradiotherapy of unresectable locally advanced pancreatic cancer using capsule endoscopy: a ca… Co-author DOI 10.20524/aog.2016.0063↗
  10. Histopathological effects of preoperative chemoradiotherapy for pancreatic cancer: an analysis for the impact of radiation and gemcitabine doses. First author DOI 10.1016/j.radonc.2015.01.004↗
  11. [The progress of chemotherapy for advanced pancreatic cancer]. Co-author DOI 10.11405/nisshoshi.112.2119↗
  12. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a… Co-author DOI 10.1120/jacmp.v14i5.4252↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hidenori Takahashi · 6 shared papers, 2015–2025 · strength 0.62
  2. Reiko Ashida · 4 shared papers, 2015–2025 · strength 0.51
  3. Shingo Ohira · 5 shared papers, 2018–2021 · strength 0.51
  4. Ryoji Takada · 4 shared papers, 2016–2025 · strength 0.51
  5. Hirofumi Akita · 3 shared papers, 2020–2025 · strength 0.45
  6. Kazuyoshi Ohkawa · 3 shared papers, 2020–2025 · strength 0.45
  7. Masahiko Koizumi · 4 shared papers, 2018–2021 · strength 0.40
  8. Kenji Ikezawa · 2 shared papers, 2021–2025 · strength 0.35
  9. Yuichiro Doki · 1 shared paper, 2025 · strength 0.24
  10. Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.24
  11. Tomomi Yasue · 1 shared paper, 2025 · strength 0.24
  12. Shigenori Nagata · 1 shared paper, 2025 · strength 0.24
  13. Tatsuya Ioka · 3 shared papers, 2015–2020 · strength 0.22
  14. Nobuyasu Fukutake · 2 shared papers, 2020–2021 · strength 0.22
  15. Kazuhiko Ogawa · 2 shared papers, 2015–2021 · strength 0.17
  16. Takero Hirata · 2 shared papers, 2015–2018 · strength 0.12
  17. Kazuhiro Katayama · 1 shared paper, 2020 · strength 0.11
  18. Kazuma Daiku · 1 shared paper, 2021 · strength 0.11
  19. Takuo Yamai · 1 shared paper, 2021 · strength 0.11
  20. Yugo Kai · 1 shared paper, 2021 · strength 0.11
  21. Makiko Urabe · 1 shared paper, 2021 · strength 0.11
  22. Hiroaki Ohigashi · 2 shared papers, 2015–2016 · strength 0.10
  23. Osamu Ishikawa · 2 shared papers, 2015–2016 · strength 0.10
  24. Keisuke Otani · 2 shared papers, 2015–2016 · strength 0.10
  25. Koji Konishi · 2 shared papers, 2015–2016 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.